One research group found that there is no standardized treatment or evaluation of treatment that is beneficial to the patient with hand and foot psoriasis (Marsland, Chalmers, Hollis, Leonardi-Bee ...

NICE has recommended broadening NHS use of Novartis' IL-17 inhibitor Cosentyx to include children aged six to 17 with severe plaque psoriasis. The cost-effectiveness agency says in draft guidance ...

Patients with hand and foot psoriasis should be viewed by dermatology professionals as a unique and distinct subpopulation, because the therapies often used to treat generalized psoriasis have ...